Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026)

Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Dil.) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	255.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	106.00 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	64.41 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	210.89 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.51 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	25.05 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	556.90 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	138.28 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	217.35 Mn
10	Lineage Cell Therapeutics	270.61 Mn	212.77 Mn	1.07 Mn	261.47 Mn

Download Data